Clinical trials and their current trials….

clinical trials, pharmacogenomics 1 Minute

Bottom line, their high cost and inability to handle individual differences in pharmaco-genomics, NYT editorial here.

Unknown's avatar

Published by jlolds

Native Angeleno, professor of Neuroscience and Public Policy at George Mason University

Published